Molecular insights into breast cancer from transgenic mouse models.
We desperately need to know more of the biological details of the onset and progression of breast cancer. The disease is of startlingly high incidence (approaching 1 in 9 women), our current therapies for the disease are inadequate once it has metastasized, and the disease is characterized by excessive morbidity and mortality. Most of the growth and differentiation of the mammary gland occurs relatively late in life: during sexual maturation, and then cyclically during pregnancy and lactation. Normal as well as malignant growth is regulated by endocrine hormones as well as by local tissue factors, such as polypeptide growth factors. Cancer seems to progress as hyperplastic ductal or lobular epithelial growth, acquiring progressive genetic changes (including those of oncogenes and tumor suppressor genes) leading to clonal outgrowths of progressively more malignant cells. The nature of proliferative controls and the relevant genetic changes are the subjects of the current review.
Dickson
R B
RB
Department of Anatomy and Cell Biology, Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC 20007.
Gottardis
M M
MM
Merlino
G T
GT
D000375:Aging; D000818:Animals; D001943:Breast Neoplasms / Q000473:pathology*; D005314:Embryonic and Fetal Development; D005260:Female; D011905:Genes, ras; D006801:Humans; D008321:Mammary Glands, Animal / Q000196:embryology / Q000254:growth & development / Q000502:physiology*; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000473:pathology*; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic